Creative Media & Community Trust Corporation is listed to report third quarter 2026 results before the market opens (BMO) on November 13, 2026. The consensus estimate per the screener snapshot is a loss of USD 3.33 per share, narrower than the second quarter loss …
Key HighlightsStrategy (NASDAQ:MSTR) will be deleted from MSCIEquityindexes effective after the close on November 30, 2026, under new eligibility rules for non-operating companies.The shares slipped about 2.6% to around USD 119.06 in after-hours trading on November 11 as the deletion was confirmed.An earlier market …
In the second quarter of 2026, selling, general and administrative expense fell to USD 9.7 million from USD 10.6 million on lower litigation fees, andResearch and Developmentexpense fell to USD 0.4 million from USD 0.9 million. First half net product revenue was USD 22.1 …
Operating expenses fell to USD 2.95 million from USD 4.53 million, mainly becausePayrolland management compensation dropped 59% to USD 1.0 million and professional fees fell 24%. Those categories include stock-based awards, so part of the improvement is non-cash. Last year's quarter also carried USD …
Key HighlightsSandisk (NASDAQ:SNDK) closed up 13.69% at about USD 977.69 on November 11, 2026, while Arm Holdings gained 12.05%.Memory makers led the rebound, with Micron up 11.89% to about USD 811.30 and Western Digital up roughly 8%.The semiconductorindexrose about 5.7% to its highest close …
The backlog surge reflects a data center customer. Management said shipments began in the fourth quarter against the roughly USD 22 million initial purchase order announced in July, at the customer's request. It is also working with several prospective data center customers on designs …
The Rationale: Last Reported Quarter and Management Outlook for Super League Enterprise, Inc. (NASDAQ:SLE)
The rebound was supported byBusinessmomentum. Bloom reported third quarter 2026 revenue of about USD 1.24 billion, up 138%, aGAAPgrossMarginof 33.8% and 2026 revenue guidance of USD 4.4 billion to USD 4.6 billion, and it has joined the S&P 500. On November 5, it announced …
Management said the lead program, iopofosine I-131, targets relapsed or refractory Waldenstrom's macroglobulinemia after exposure to BTK inhibitors. On the call, it cited a subgroup analysis from the CLOVER-WaM study showing a major response rate of 79.2% and a median duration of response of …
For the quarter ended June 30, 2026, revenue was USD 33 thousand, operating expenses were about USD 7.1 million including USD 0.9 million of stock-based compensation, and the non-GAAP adjusted net loss was about USD 1.7 million, or USD 0.27 per share. No numerical …